ANEB Anebulo Pharmaceuticals Inc

NASDAQ
$0.33

Anebulo Pharmaceuticals Inc (ANEB) is expected to report earnings on October 5, 2026, after the market close.

Earnings Date
Oct 5
Monday · 4:05 PM ET
Earnings Whisper
-
vs -
Volatility
Enter your expectations below to reveal the current volatility.
Trend Analysis
Expectation
Earnings
Price action
Signals
Score
Sentiment
Grade
Life Cycle
Call Analysis
Earnings-AVWAP -

Sign in or subscribe to unlock sentiment, short interest, and technical indicators.

About Anebulo Pharmaceuticals Inc

Anebulo Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company developing novel solutions for people suffering from acute cannabinoid intoxication and substance abuse disorder.

Industry

Biotechnology

Charts powered in part by Lightweight Charts™ by TradingView.